PublizoomAward notice Supplies
suministro de los principios activos denominados "RALTEGRAVIR POTASIO 400 MG" Y "TEDIZOLID 200MG ORAL " para el Hospital Universitario de Gran Canaria Dr. Negrín.
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria - Place of performance
- Las Palmas de Gran Canaria
- Estimated value
- €187,264 excl. VAT
- Amount awarded
- €187,264 excl. VAT
- Bids received
- 1
- Procedure
- Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part. - Publication
- 12 August 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
El objeto del contrato viene determinado por el suministro de los principios activos denominados "RALTEGRAVIR POTASIO400 MG" Y "TEDIZOLID 200 MG ORAL " para el Hospital Universitario de Gran Canaria Dr. Negrín.Dicho objeto corresponde al código 33690000-3 (Medicamentos diversos), de la nomenclatura Vocabulario Común deContratos (CPV) de la Comisión Europea.
Awarded to
2 lots
- raltegraavir potasio 400 mg
- tedizolid 200 mg oral
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €202,502
- Median
- €425,325
- A quarter above
- €1,046,198
Amounts awarded (excl. VAT) over the last 3 years for 163 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 557482-2026.